Cameco Corporation (USA)  

(Public, NYSE:CCJ)   Watch this stock  
Find more results for CCJ
14.02
+0.11 (0.79%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 13.63 - 14.24
52 week 13.63 - 25.84
Open 13.74
Vol / Avg. 2.41M/2.01M
Mkt cap 5.61B
P/E 142.47
Div/yield 0.09/2.45
EPS 0.10
Shares 395.79M
Beta 1.63
Inst. own 70%
Feb 24, 2015
Cameco Corp at BMO Capital Markets Global Metals & Mining Conference - 10:00AM EST - Add to calendar
Feb 9, 2015
Q4 2014 Cameco Corp Earnings Call - 11:00AM EST - Add to calendar
Feb 9, 2015
Q4 2014 Cameco Corp Earnings Release - 9:30AM EST - Add to calendar
Jan 22, 2015
Cameco Corp at CIBC Whistler Institutional Investor Conference
Dec 2, 2014
Cameco Corp at Scotiabank Mining Conference
Nov 24, 2014
Cameco Corp 2014 Investor Workshop
Nov 11, 2014
Cameco Corp at Cowen Global Metals, Mining and Materials Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -24.94% 13.03%
Operating margin -18.33% 10.85%
EBITD margin - 25.60%
Return on average assets -6.92% 4.11%
Return on average equity -10.66% 6.19%
Employees 3,470 -
CDP Score - 64 D

Address

2121-11th Street West
SASKATOON, SK S7M 1J3
Canada
+1-306-9566200 (Phone)
+1-306-9566201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha

Description

Cameco Corporation (Cameco) is primarily engaged in the exploration for and the development, mining, refining, conversion, fabrication and trading of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. Cameco has four reportable segments: uranium, fuel services, electricity and NUKEM. The uranium segment involves the exploration for, mining, milling, purchase and sale of uranium concentrate. The fuel services segment involves the refining, conversion and fabrication of uranium concentrate and the purchase and sale of conversion services. The electricity segment involves the generation and sale of electricity. The NUKEM segment acts as a market intermediary between uranium producers and nuclear-electric utilities.

Officers and directors

Timothy S. Gitzel President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Grant E. Isaac Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
Robert A. Steane Chief Operating Officer, Senior Vice President
Bio & Compensation  - Reuters
Kenneth A. Seitz Senior Vice President, Chief Compliance Officer
Bio & Compensation  - Reuters
Sean Quinn Senior Vice President, Chief Legal Officer, Corporate Secretary
Bio & Compensation  - Reuters
Alice Wong Senior Vice President, Chief Corporate Officer
Bio & Compensation  - Reuters
Donald H. F. Deranger Director
Age: 58
Bio & Compensation  - Reuters
Catherine A. Gignac Director
Age: 52
Bio & Compensation  - Reuters
Victor J. Zaleschuk Director
Age: 70
Bio & Compensation  - Reuters
Ian D. Bruce Independent Director
Age: 60
Bio & Compensation  - Reuters